IP Library Granted Patent US 10,864,205
Granted Patent B2
US 10,864,205 · App. 15/829,822 · Granted Dec 15, 2020

Nutritional supplement for improving sexual health in men and women

Inventor: Bassam Damaj (San Diego, CA)
Assignee: Innovus Pharmaceuticals, Inc.
A61K31/4525A23L33/105A23L33/16A23L33/175A61K9/0053A61K9/146A61K9/4866A61K31/00A61K31/198A61K36/67A61K47/02A61K47/12A61K47/38A61P15/00A61P15/10A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,864,205
App. No.
15/829,822
Granted
Dec 15, 2020
Kind
B2
Abstract

The invention provides compositions and methods that are effective to improve NO production in vivo and/or to increase NO levels in blood. Such compositions and methods are useful to improve sexual function in males and females.

Claims (8)

1. A unit dosage form suitable for oral administration to a human comprising:

about 500 mg of L-citrulline;

about 250 mg of L-arginine; and

from 1.75 mg to 5 mg piperine.

2. The unit dosage form of claim 1 that further comprises microcrystalline cellulose, silicon dioxide, and magnesium stearate.

3. The unit dosage form of claim 1 wherein the piperine is synthetically produced piperine.

4. The unit dosage form of claim 1 wherein the piperine is an extract from the fruit of Piper.

5. The unit dosage form of claim 1 that is formulated as a powder or liquid.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 067728/0206 →
PARTIAL RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 16, 2023
From: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
To: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.; AYTU BIOPHARMA, INC.; NOVALERE, INC.
Reel/Frame 065241/0560 →
SECURITY INTEREST Recorded Feb 10, 2022
From: INNOVUS PHARMACEUTICALS, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 058976/0706 →
SECURITY INTEREST Recorded Jan 27, 2022
From: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.
To: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
Reel/Frame 058789/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: DAMAJ, BASSAM
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 047624/0203 →